Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma

Hussain, MJ; Robinson, MM; Hamadeh, I; Arnall, J; Bhutani, M; Atrash, S; Friend, R; Pineda-Roman, M; Symanowski, JT; Usmani, SZ; Voorhees, PM

Voorhees, PM (reprint author), Atrium Hlth, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC 28203 USA.

BRITISH JOURNAL OF HAEMATOLOGY, 2019; 186 (1): 140